WHAT MAKES P450s WORK? SEARCHES FOR ANSWERS WITH KNOWN AND NEW P450s*

REFERENCES

• Coon M. J., Ding X., Pernecky S. J., Vaz A. D.N. Cytochrome P450: Progress and predictions. FASEB J. 1992; 6: 669–673
   PubMed Web of Science ®Google Scholar
• Cytochrome P450: Structure, Mechanism, and Biochemistry, P. R. Ortiz de Montellano. 2nd ed., Plenum Press, New York 1995
   Google Scholar
• Guengerich F. P. Human cytochrome P450 enzymes. Cytochrome P450, P. R. Ortiz de Montellano. 2nd ed., Plenum Press, New York 1995; 473–535
   Google Scholar
• Guengerich F. P. Reactions and significance of cytochrome P-450 enzymes. J. Biol. Chem. 1991; 266: 10,019–10,022
   Google Scholar
• Mueller E. J., Loida P. J., Sligar S. G. Twenty-five years of P450cam research: Mechanistic insights into oxygenase catalysis. Cytochrome P450: Structure, Mechanism, and Biochemistry, P. R. Ortiz de Montellano. 2nd ed., Plenum Press, New York 1995; 83–124
   Google Scholar
• Bradshaw W. H., Conrad H. E., Corey E. J., Gunsalus I. C., Lednicer D. Degradation of (+)–camphor. J. Am. Chem. Soc. 1991; 81: 5007
   Google Scholar
• Hasemann C. A., Ravichandran K. G., Peterson J. A., Deisenhofer J. Crystal structure and refinement of cytochrome P450terp at 2.3 Å resolution. J. Molec. Biol. 1994; 236: 1169–1185
   PubMed Web of Science ®Google Scholar
• Fulco A. J. P450BM–3 and other inducible bacterial P450 cytochromes: Biochemistry and regulation. Annu. Rev. Pharmacol. Toxicol. 1991; 31: 177–203
   PubMed Web of Science ®Google Scholar
• Hosny G., Roman L. J., Mostafa M. H., Masters B. S.S. Unique properties of purified. Escherichia coli–expressed constitutive cytochrome P4504A5, Arch. Biochem. Biophys. 1999; 366: 199–206
   PubMed Web of Science ®Google Scholar
• Bell L. C., Guengerich F. P. Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate-limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b5 on steady-state kinetics. J. Biol. Chem. 1997; 272: 29,643–29,651
   Google Scholar
• Bell-Parikh L. C., Guengerich F. P. Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde. J. Biol. Chem. 1999; 274: 23,833–23,840
   Google Scholar
• de Montellano P. R. Ortiz. Oxygen activation and reactivity, in Cytochrome P450. Structure, Mechanism, and Biochemistry, P. R. Ortiz de Montellano. 2nd ed., Plenum Press, New York 1995; 245–303
   Google Scholar
• Sligar S. G., Maves S. A unified mechanism of oxygen activation as determined by cryocrystallography. Abstracts, 9th North American Meeting. Int. Soc. Study Xenobiotics/Amer. Chem. Soc.—Div. Chem. Toxicol. 2nd ed., Nashville October 1999; 15
   Google Scholar
• Hermes J. D., Blacklow S. C., Knowles J. R. Searching sequence space by definably random mutagenesis: Improving the catalytic potency of an enzyme. Proc. Natl. Acad. Sci. USA 1990; 87: 696–700
   PubMed Web of Science ®Google Scholar
• Chen K., Arnold F. H. Enzyme engineering for nonaqueous solvents: Random mutagenesis to enhance activity of subtilisin E in polar organic media. Bio/Technology 1991; 9: 1073–1077
   PubMedGoogle Scholar
• Laine R., de Montellano P. R. Ortiz. Directed evolution of the P450cam specificity. FASEB J. 1997; 11: A811
   Web of Science ®Google Scholar
• Fisher C. W., Shet M. S., Faulkner K. M., Estabrook R. W. A visual screening method for identification of functional mutants of recombinant P450 1A2. Abstracts, 11th Int. Sympos. Microsomes and Drug Oxidations. 2nd ed., Los Angeles July 1996; 222
   Google Scholar
• Harlow G. R., Halpert J. R. Alanine-scanning mutagenesis of a putative substrate recognition site in human cytochrome P450 3A4: Role of residues 210 and 211 in flavonoid activation and substrate specificity. J. Biol. Chem. 1997; 272: 5396–5402
   PubMed Web of Science ®Google Scholar
• Dong M.-S., Bell L. C., Guo Z., Phillips D. R., Blair I. A., Guengerich F. P. Identification of retained N–formylmethionine in bacterial recombinant cytochrome P450 proteins with the N-terminal sequence MALLLAVFL …: Roles of residues 3–5 in retention and membrane topology. Biochemistry 1996; 35: 10,031–10,040
   Google Scholar
• Maves S. A., Sligar S. G. Directed evolution of cytochrome P450 thermostability. Abstracts, 11th Int. Meetg. Cytochrome P450. Sendai 29 August–2 September 1999; 118
   Google Scholar
• Parikh A., Guengerich F. P. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:NADPH–cytochrome P450 reductase fusion protein. Protein Express. Purif. 1997; 9: 346–354
   PubMed Web of Science ®Google Scholar
• Dong M.-S., Yamazaki H., Guo Z., Guengerich F. P. Recombinant human cytochrome P450 1A2 and an N-terminal truncated form: Construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH–cytochrome P450 reductase. Arch. Biochem. Biophys. 1996; 327: 11–19
   PubMed Web of Science ®Google Scholar
• Parikh A., Gillam E. M.J., Guengerich F. P. Drug metabolism by Escherichia coli expressing human cytochromes P450. Nature Biotechnol. 1997; 15: 784–788
   PubMed Web of Science ®Google Scholar
• Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analysis of amino acid and coding nucleotide sequences. J. Biol. Chem. 1992; 267: 83–90
   PubMed Web of Science ®Google Scholar
• Parikh A., Guengerich F. P. Random mutagenesis via whole plasmid PCR amplification. BioTechniques 1998; 24: 428–431
   PubMed Web of Science ®Google Scholar
• Josephy P. D., Evans D. H., Parikh A., Guengerich F. P. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH–cytochrome P450 reductase, and N-acetyltransferase. Escherichia coli, Chem. Res. Toxicol. 1998; 11: 70–74
   PubMed Web of Science ®Google Scholar
• Parikh A., Josephy P. D., Guengerich F. P. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties. Biochemistry 1999; 38: 5283–5289
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Analysis and characterization of enzymes. Principles and Methods of Toxicology, A. W. Hayes. Raven Press, New York 1994; 1259–1313
   Google Scholar
• Guengerich F. P, Peterson L. A., Bocker R. H. Cytochrome P-450-catalyzed hydroxylation and carboxylic acid ester cleavage of Hantzsch pyridine esters. J. Biol. Chem. 1988; 263: 8176–8183
   PubMed Web of Science ®Google Scholar
• Vaz A. D. N., Coon M. J. On the mechanism of action of cytochrome P450: Evaluation of hydrogen abstraction in oxygen-dependent alcohol oxidation. Biochemistry 1994; 33: 6442–6449
   PubMed Web of Science ®Google Scholar
• Joo H., Lin Z., Arnold F. H. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation. Nature 1999; 399: 670–673
   PubMed Web of Science ®Google Scholar
• Joo H., Arisawa A., Lin Z. L., Arnold F. H. A high-throughput digital imaging screen for the discovery and directed evolution of oxygenases. Chem. Biol. 1999; 6: 699–706
   PubMed Web of Science ®Google Scholar
• Aryal P., Yoshikawa K., Terashita T., Guengerich F. P., Shimada T., Oda Y. Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human cytochrome P450 1A2 and NADPH–cytochrome P450 reductase. Mutat. Res. 1999; 442: 113–120
   PubMed Web of Science ®Google Scholar
• Shimada T., Oda Y., Yamazaki H., Mimura M., Guengerich F. P. SOS function tests for studies of chemical carcinogenesis in Salmonella typhimurium TA 1535/pSK1002, NM2009, and NM3009. Gene and Chromosome Analysis Methods in Molecular Genetics, K. W. Adolph. Academic Press, Orlando, FL 1994; 5: 342–355
   Google Scholar
• Glatt H., Pauly k., Czich A., Falany J. L., Falany C. N. Activation of benzylic alcohols to mutagens by rat and human sulfotransferases expressed. Escherichia coli, Eur. J. Pharmacol. 1995; 293: 173–181
   PubMed Web of Science ®Google Scholar
• Cmarik J. L., Humphreys W. G., Bruner K. L., Lloyd R. S., Tibbetts C., Guengerich F. P. Mutation spectrum and sequence alkylation selectivity resulting from modification of bacteriophage M13mp18 with S-(2-chloroethyl)glutathione. Evidence for a role of S-[2-(N7-guanyl)ethyl]glutathione as a mutagenic lesion formed from ethylene dibromide. J. Biol. Chem. 1992; 267: 6672–6679
   PubMed Web of Science ®Google Scholar
• Grant D. M., Josephy P. D., Lord H. L., Morrison L. D. Salmonella typhimurium strains expressing human arylamine N–acetyltransferases: Metabolism and mutagenic activation of aromatic amines. Cancer Res. 1992; 52: 3961–3964
   PubMed Web of Science ®Google Scholar
• Gillam E. M.J., Notley L. M., Kim D., Mundkowski R. G., Aguinaldo A. M., Volkov A., Arnold F. H., Soucek P., DeVoss J., Guengerich F. P. Formation of indigo by recombinant human cytochrome P450. Biochem. Biophys. Res. Commun. 1999; 265: 469–472
   PubMed Web of Science ®Google Scholar
• Bialy H. Biotechnology, bioremediation, and blue genes. Nature Biotechnol. 1997; 15: 110
   PubMed Web of Science ®Google Scholar
• Russell G. A., Kaupp G. Oxidation of carbanions. IV. Oxidation of indoxyl to indigo in basic solution. J. Am. Chem. Soc. 1969; 91: 3851–3859
   Web of Science ®Google Scholar
• King L. J., Parke D. V., Williams R. T. The metabolism of [2-14C]indole in the rat. Biochem. J. 1966; 98: 266–277
   PubMed Web of Science ®Google Scholar
• Sapira J. D., Somani S., Shapiro A. P., Scheib E. T., Reihl W. Mammalian indoxyl metabolism and its relation to the formation of urinary indigo pigments. Metab. Clin. Exp. 1971; 20: 474–486
   PubMed Web of Science ®Google Scholar